LTRN icon

Lantern Pharma
LTRN

Overview Fund Activity

5 hedge funds and large institutions have $1.55M invested in Lantern Pharma in 2020 Q2 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
+5
Holders Change %
–
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
ZCA
Zeke Capital Advisors
Pennsylvania
+$1.52M
2
UBS Group
UBS Group
Switzerland
+$19K
3
US Bancorp
US Bancorp
Minnesota
+$3K
4
TRCT
Tower Research Capital (TRC)
New York
+$2K
5
TI
tru Independence
Oregon
+$6

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Shares
Change %
ZCA
1
Zeke Capital Advisors
Pennsylvania
$1.52M +$1.52M +119,750 New
UBS Group
2
UBS Group
Switzerland
$19K +$19K +1,533 New
US Bancorp
3
US Bancorp
Minnesota
$3K +$3K +200 New
TRCT
4
Tower Research Capital (TRC)
New York
$2K +$2K +170 New
TI
5
tru Independence
Oregon
$6 +$6 +500 New